Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    November 2018
  1. YAN W, Li SX, Wei M, Gao H, et al
    Identification of MMP9 as a novel key gene in mantle cell lymphoma based on bioinformatic analysis and design of cyclic peptides as MMP9 inhibitors based on molecular docking.
    Oncol Rep. 2018;40:2515-2524.
    PubMed     Text format     Abstract available


    October 2018
  2. HUANG Y, Zou Y, Lin L, Ma X, et al
    miR101 regulates the cell proliferation and apoptosis in diffuse large Bcell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway.
    Oncol Rep. 2018 Oct 24. doi: 10.3892/or.2018.6821.
    PubMed     Text format     Abstract available


  3. ZHUANG L, Lai J, Chen K, Ding T, et al
    Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
    Oncol Rep. 2018 Oct 11. doi: 10.3892/or.2018.6781.
    PubMed     Text format     Abstract available


  4. KALAVSKA K, Kucerova L, Schmidtova S, Toro L, et al
    Lymphoma transformation of tumor infiltrating lymphocytes observed in testicular patientderived xenograft models.
    Oncol Rep. 2018 Oct 5. doi: 10.3892/or.2018.6769.
    PubMed     Text format     Abstract available


    September 2018
  5. NIU X, Ji H, Wang Y, Hu S, et al
    Systemic immune response associated with radiation therapy in Bcell nonHodgkin's lymphoma of Waldeyer's ring.
    Oncol Rep. 2018 Sep 28. doi: 10.3892/or.2018.6748.
    PubMed     Text format     Abstract available


    January 2018
  6. SONG YH, Zhong MZ, Chai Q, Gong KY, et al
    The role of aldehyde dehydrogenase 1A1 in B-cell non-Hodgkin's lymphoma.
    Oncol Rep. 2018 Jan 18. doi: 10.3892/or.2018.6220.
    PubMed     Text format     Abstract available


    December 2017
  7. KARAM L, Houshaymi B, Abdel-Samad R, Jaafar M, et al
    Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
    Oncol Rep. 2017 Dec 5. doi: 10.3892/or.2017.6137.
    PubMed     Text format     Abstract available


    September 2017
  8. ISHIKAWA C, Mori N
    In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida.
    Oncol Rep. 2017 Sep 20. doi: 10.3892/or.2017.5978.
    PubMed     Text format     Abstract available


  9. LI XY, Li Y, Zhang L, Liu X, et al
    The antitumor effects of arsenic trioxide in mantle cell lymphoma via targeting Wnt/betacatenin pathway and DNA methyltransferase-1.
    Oncol Rep. 2017 Sep 7. doi: 10.3892/or.2017.5945.
    PubMed     Text format     Abstract available


    July 2017
  10. GAO HY, Wu B, Yan W, Gong ZM, et al
    Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma.
    Oncol Rep. 2017 Jul 14. doi: 10.3892/or.2017.5821.
    PubMed     Text format     Abstract available


    June 2017
  11. ZHOU X, Zhang Y, Li Y, Xu Y, et al
    Klotho suppresses tumor progression via inhibiting IGF-1R signaling in Tcell lymphoma.
    Oncol Rep. 2017 Jun 22. doi: 10.3892/or.2017.5744.
    PubMed     Text format     Abstract available


    May 2017
  12. DOU A, Wang Z, Zhang N, Liu J, et al
    Loss of Reelin suppresses cell survival and mobility in non-Hodgkin lymphoma.
    Oncol Rep. 2017 May 4. doi: 10.3892/or.2017.5626.
    PubMed     Text format     Abstract available


    February 2017
  13. OKUYAMA H, Tominaga A, Fukuoka S, Taguchi T, et al
    Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-gamma.
    Oncol Rep. 2017;37:684-694.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: